• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.52% Nasdaq Down 0.81%

    Sarepta Therapeutics, Inc. (SRPT)

    -NasdaqGS
    33.90 Up 0.37(1.10%) 10:49AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:33.53
    Open:32.99
    Bid:34.04 x 100
    Ask:34.12 x 200
    1y Target Est:39.69
    Beta:-0.138814
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:32.29 - 34.46
    52wk Range:11.33 - 37.39
    Volume:472,012
    Avg Vol (3m):1,290,230
    Market Cap:1.41B
    P/E (ttm):N/A
    EPS (ttm):-4.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRPT

    Comparison

    Symbol% ChgMkt Cap
    SRPTUp 1.10%1.41B
    GSKDown 2.19%96.03B
    ISISUp 0.39%6.21B
    ALNYUp 0.59%8.28B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,281.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-4.86
    Quarterly EPS Est (Sep-15) :-1.19
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):37.95

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sarepta Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery and development of RNA-based therapeutics for the treatment of rare, infectious, and other diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback